These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16475959)

  • 1. Serotonin-dopamine interaction as a focus of novel antidepressant drugs.
    Esposito E
    Curr Drug Targets; 2006 Feb; 7(2):177-85. PubMed ID: 16475959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review.
    Bonhomme N; Esposito E
    J Clin Psychopharmacol; 1998 Dec; 18(6):447-54. PubMed ID: 9864076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin(2C) receptors in the control of brain dopaminergic function.
    Di Matteo V; Cacchio M; Di Giulio C; Esposito E
    Pharmacol Biochem Behav; 2002 Apr; 71(4):727-34. PubMed ID: 11888564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
    Alex KD; Pehek EA
    Pharmacol Ther; 2007 Feb; 113(2):296-320. PubMed ID: 17049611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of 5-HT(2C) receptors in the control of central dopamine function.
    Di Matteo V; De Blasi A; Di Giulio C; Esposito E
    Trends Pharmacol Sci; 2001 May; 22(5):229-32. PubMed ID: 11339973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
    Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.
    Dremencov E; Weizmann Y; Kinor N; Gispan-Herman I; Yadid G
    Curr Drug Targets; 2006 Feb; 7(2):165-75. PubMed ID: 16475958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group.
    Nocjar C; Roth BL; Pehek EA
    Neuroscience; 2002; 111(1):163-76. PubMed ID: 11955720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies.
    Millan MJ
    Therapie; 2005; 60(5):441-60. PubMed ID: 16433010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin-dopamine interaction: electrophysiological evidence.
    Di Giovanni G; Di Matteo V; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():45-71. PubMed ID: 18772027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.